Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06125041 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 9, 2023 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To observe the efficacy and safety of adebelizumab combined with chemotherapy and sequential adebelizumab combined with radiotherapy in the treatment of newly diagnosed extensive small cell lung cancer.
Trial Details
NCT Number NCT06125041
Lead Sponsor Qianfoshan Hospital
Conditions
(from sponsor)		 Extensive Small Cell Lung Cancer
Enrollment 51 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov